BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22764137)

  • 1. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors.
    Dumont AG; Yang Y; Reynoso D; Katz D; Trent JC; Hughes DP
    Carcinogenesis; 2012 Sep; 33(9):1674-83. PubMed ID: 22764137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.
    Serrano-Candelas E; Ainsua-Enrich E; Navinés-Ferrer A; Rodrigues P; García-Valverde A; Bazzocco S; Macaya I; Arribas J; Serrano C; Sayós J; Arango D; Martin M
    Mol Oncol; 2018 Aug; 12(8):1383-1397. PubMed ID: 29885053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.
    Wang Y; Li J; Kuang D; Wang X; Zhu Y; Xu S; Chen Y; Cheng H; Zhao Q; Duan Y; Wang G
    Cell Commun Signal; 2018 Apr; 16(1):16. PubMed ID: 29661252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch pathway activation induces neuroblastoma tumor cell growth arrest.
    Zage PE; Nolo R; Fang W; Stewart J; Garcia-Manero G; Zweidler-McKay PA
    Pediatr Blood Cancer; 2012 May; 58(5):682-9. PubMed ID: 21744479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors.
    Chen W; Kuang Y; Qiu HB; Cao Z; Tu Y; Sheng Q; Eilers G; He Q; Li HL; Zhu M; Wang Y; Zhang R; Wu Y; Meng F; Fletcher JA; Ou WB
    Cancer Res; 2017 Sep; 77(18):5107-5117. PubMed ID: 28760855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors.
    Ou WB; Zhu MJ; Demetri GD; Fletcher CD; Fletcher JA
    Oncogene; 2008 Sep; 27(42):5624-34. PubMed ID: 18521081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
    Hemming ML; Lawlor MA; Andersen JL; Hagan T; Chipashvili O; Scott TG; Raut CP; Sicinska E; Armstrong SA; Demetri GD; Bradner JE
    Cancer Res; 2019 Mar; 79(5):994-1009. PubMed ID: 30630822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.
    Mühlenberg T; Zhang Y; Wagner AJ; Grabellus F; Bradner J; Taeger G; Lang H; Taguchi T; Schuler M; Fletcher JA; Bauer S
    Cancer Res; 2009 Sep; 69(17):6941-50. PubMed ID: 19706776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.
    Rausch JL; Boichuk S; Ali AA; Patil SS; Liu L; Lee DM; Brown MF; Makielski KR; Liu Y; Taguchi T; Kuan SF; Duensing A
    Oncotarget; 2017 Jan; 8(3):4471-4483. PubMed ID: 27965460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
    Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
    Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.
    Boichuk S; Galembikova A; Dunaev P; Valeeva E; Shagimardanova E; Gusev O; Khaiboullina S
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.
    Cohen NA; Zeng S; Seifert AM; Kim TS; Sorenson EC; Greer JB; Beckman MJ; Santamaria-Barria JA; Crawley MH; Green BL; Rossi F; Besmer P; Antonescu CR; DeMatteo RP
    Cancer Res; 2015 May; 75(10):2061-70. PubMed ID: 25836719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Translational research and diagnosis in GIST].
    Wardelmann E
    Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.